In last 5 months patient has received 24 units of packed red cells. Oxymetholone (Anapolon) 100 mg daily for 3 months had no effect on rate of fall of Hb level.
Comment
Pyoderma gangrenosum has sometimes been seen to be associated with abnormal T-cell function (Delescluse et al. 1972 , Lazarus et al. 1972 ) but it has not previously been reported to occur with pure red cell aplasia. Post-plasmaphoresis healing of ulcers continued after the return of the circulating blocking factor and with no change in T-cell function suggesting that the immunological abnormalities were not the cause of the pyoderma.
Acquired idiopathic pure red cell aplasia is often associated with neoplasia which in about 50 % of cases is a thymoma (Hamilton & Conley 1969) . In vivo and in vitro studies in these patients have demonstrated serum inhibitors of erythropoiesis. These are of the IgG class and either inhibit erythroid precursors or are anti-erythropoietin (Krantz 1973 , Marmont et al. 1975 Professor Malcolm Greaves: It would be interesting to know the erythropoietin levels in this patient. The patient's lymphocytes were unresponsive to mitogens and it is interesting to speculate that a membrane receptor defect might cause both this and an insensitivity to erythropoietin, thus explaining both the cellular immunity defect and the red cell aplasia.
Dr L Forman: I would be interested to know whether the bacterial flora were of any significance. I have seen this type of ulcer clear surprisingly well with antibiotic, even in the presence of a cellular immunity defect. Relief of a bacterial overload, even with an immunity deficiency, might allow healing to occur.
Dr J S Pegum: Some pictures of this patient show a bullous and vesicular appearance round the ulcers. The bullous form of pyoderma gangrenosum may be associated with leuk2emia. We showed a patient with bullous pyoderma gangrenosum at the summer meeting of the British Association of Dermatologists in 1969. Our patient had quite severe anxmia and later developed leukaemia. This patient and also another patient described by Dr John Burton had some clinical features of Sweet's disease. Erythropoietic protoporphyria (EPP) is a disorder, usually of autosomal dominant inheritance, in which large amounts of protoporphyrin are found in erythrocytes; increased levels may also be present in the plasma and feces. Our patient, in addition to many typical features of the disease, was found to have onycholysis. Section of Dermatology History S J H, girl aged 9 At the age of two years the patient was noted to cry and scratch when exposed to sunlight and this tendency has persisted. After a few minutes in the sun she experienced burning and itching of the skin which was partially relieved by the application of cold water. Two or three days later the exposed skin became red and edematous; urticarial and eczematous lesions also occurred (Fig 1) . Symptoms were present throughout the year but were much worse in summer; window glass did not protect her. There was no relevant family history, she had one sibling who was normal.
On examination, pitted scars were seen on the forehead, nose and cheeks, as well as on the backs of the hands which were wrinkled.
Onycholysis of the thumb nails was observed in August 1976, during a prolonged period of sunny weather when the patient suffered considerable discomfort (Fig 2) . Shortly afterwards the skin improved and within three months the nails were normal.
The patient was investigated at the Institute of Dermatology, Homerton Grove, London in 1974 when the diagnosis of EPP was confirmed. The blood protoporphyrin concentration was 482.21 j.g/I00 ml (normal = 0-45) and blood coproporphyrin 4.63 j.g/100 ml (normal 0-4.2). There was no excess of porphyrin in the urine; faces were not examined. Ultraviolet microscopy of a peripheral blood film showed many fluorescent erythrocytes. Monochromator tests with wave lengths 360-500 nm were normal. The patient would not consent to a skin biopsy and has refused to give further blood samples. Porphyrin assays of maternal blood were normal.
Topical light screening preparations, including amyl dimethylaminobenzoate (Spectraban) and 5 % titanium dioxide in emulsifying ointment (with 2 % burnt sugar) were unhelpful. Treatment with beta-carotene, 50 mg daily orally, was started in June 1975 with relief from symptoms and increased tolerance to sunlight. During the second summer of treatment when it was unusually sunny, several acute exacerbations occurred despite continuous therapy -Maximum dose of beta-carotene was 100 mg daily.
Discussion
Most patients with EPP seem to benefit from treatment with oral beta-carotene (Pollitt 1975). Our patient responded well during the first summer of therapy but improvement was not sustained. Unfortunately the effects of betacarotene treatment in EPP are notoriously difficult to assess objectively since neither the results of monochromator skin tests nor blood porphyrin levels correlate with clinical response (Zaynoun et al. 1977) .
A relatively small dose of betacarotene (50-100 mg daily) was given to the patient because of her age, nevertheless the skin became markedly yellow in colour. Since vitamin A blood levels could not be monitored it was thought inadvisable to increase the dose when her condition relapsed (Pollitt 1975 but. may be found in other photosensitivity reactions. 'Photo-onycholysis', with nail discomfort, was first noted in tetracycline-induced light sensitivity (Orentreich et al. 1961 , Frank et al. 1971 ) and later in a young woman with porphyria cutanea tarda who was taking the contraceptive pill (Byrne et al. 1976) . We have recently observed onycholysis of the finger nails in an alcoholic with porphyria cutanea tarda and in a man with actinic reticuloid (Fig 3) . These changes seem to occur when the disease is active and in our patient with EPP the nails became normal during a period of remission. (Table 1) . These included some patients who had not been satisfied with the effect of the earlier dose. In March-April 1976 the dose was 120 mg/day and it was increased in May or June to 150 mg/day, and in July or August to 180 mg/day. The patients stated that they were satisfied with the increasing length of time which they could spend in outdoor activities without symptoms. However, conclusions cannot be established until after a similar controlled trial. Despite the increased doses and high serum ,6-carotene levels (620-1040 gg/100 ml), serum vitamin A levels remained within normal limits in all patients (including 3 children). The drug did not affect the basic metabolic fault, and the RBC protoporphyrin remained high (599-2688 gg/100 ml packed cells). It is possible that the carotene in the skin may act by a filtering effect but it seems more probable that amelioration of the photosensitive symptoms is attributable to the quenching of excited singlet oxygen or the free radicals which participate in the early stages of the photodynamic action.
